Please try another search
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
AddLife | 112.90 | 114.00 | 112.00 | -0.30 | -0.27% | 14.18K | 09:26:02 | ||
Arjo | 46.78 | 47.06 | 45.96 | +0.56 | +1.21% | 103.48K | 09:27:15 | ||
Bactiguard Holding AB | 68.80 | 69.00 | 67.00 | -0.60 | -0.86% | 644.00 | 08:25:27 | ||
BICO Group | 44.12 | 45.78 | 44.12 | -0.52 | -1.16% | 40.65K | 09:33:47 | ||
Boule Diagnostics | 10.00 | 10.50 | 9.98 | -0.05 | -0.50% | 1.93K | 08:25:29 | ||
C-Rad | 41.80 | 41.95 | 41.45 | +0.15 | +0.36% | 18.99K | 09:16:40 | ||
CellaVision AB | 252.50 | 254.50 | 250.50 | 0.00 | 0.00% | 3.46K | 09:31:12 | ||
Elekta B | 86.00 | 87.40 | 86.00 | -0.75 | -0.86% | 743.17K | 09:40:44 | ||
Episurf Medical AB | 0.32 | 0.35 | 0.31 | -0.01 | -3.48% | 877.54K | 09:36:39 | ||
Getinge B | 190.5 | 192.1 | 186.6 | +1.4 | +0.71% | 821.29K | 09:39:00 | ||
Immunovia publ AB | 1.36 | 1.45 | 1.34 | 0.00 | 0.00% | 132.18K | 09:27:28 | ||
Ortivus A | 4.960 | 4.980 | 4.960 | -0.020 | -0.40% | 630.00 | 09:00:02 | ||
Ortivus B | 2.510 | 2.530 | 2.450 | -0.020 | -0.79% | 7.69K | 08:39:46 | ||
Q linea | 2.35 | 2.39 | 2.27 | +0.09 | +3.75% | 89.33K | 09:38:11 | ||
RaySearch Labs B | 141.00 | 141.60 | 139.40 | -0.20 | -0.14% | 21.85K | 09:38:55 | ||
Sectra | 240.80 | 242.60 | 240.20 | -1.20 | -0.50% | 23.06K | 09:39:46 | ||
Sedana Medical | 21.25 | 21.65 | 21.00 | -0.15 | -0.70% | 33.84K | 09:36:02 | ||
Senzime | 6.3700 | 6.5800 | 6.2900 | -0.1300 | -2.00% | 67.45K | 09:32:19 | ||
Vitrolife | 186.20 | 187.40 | 179.90 | +1.60 | +0.87% | 18.31K | 09:33:18 | ||
Xvivo Perfusion AB | 398.50 | 403.00 | 395.50 | -3.50 | -0.87% | 9.53K | 09:26:36 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review